Pembrolizumab and salvage chemotherapy in EGFR T790M-positive non-small-cell lung cancer with high PD-L1 expression

Immuno-checkpoint inhibitors (ICI) have become an effective treatment option for non-small-cell lung cancer patients. However, ICI therapy was reported to be less effective in patients with epidermal growth factor receptor (EGFR) mutations than in those with wild-type EGFR. We report here that an no...

Full description

Saved in:
Bibliographic Details
Published in:Onco Targets Ther
Main Authors: Tozuka, Takehiro, Seike, Masahiro, Minegishi, Yuji, Kitagawa, Shingo, Kato, Tomomi, Takano, Natsuki, Hisakane, Kakeru, Takahashi, Satoshi, Kobayashi, Kenichi, Kashiwada, Takeru, Sugano, Teppei, Takeuchi, Susumu, Kunugi, Shinobu, Noro, Rintaro, Saito, Yoshinobu, Kubota, Kaoru, Gemma, Akihiko
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135433/
https://ncbi.nlm.nih.gov/pubmed/30237726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S168598
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items